Published in Lancet on September 02, 1989
Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet (1990) 4.18
Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest (1996) 1.50
Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse). Transplantation (1992) 1.23
An odyssey of islet transplantation for therapy of type 1 diabetes. World J Surg (2007) 0.90
Maintenance of stimulus-secretion coupling and single beta-cell function in cryopreserved-thawed human islets of Langerhans. Pflugers Arch (2005) 0.82
Islet cell allotransplantation in diabetic patients. Histologic findings in four adults simultaneously receiving kidney or liver transplants. Am J Pathol (1992) 0.81
Pathophysiology of diabetes. A review of selected recent developments and their impact on treatment. Drugs (1992) 0.76
Pancreatic Islet Cell Transplantation: A new era in transplantation. Can Fam Physician (1992) 0.75
Generation of transplantable Beta cells for patient-specific cell therapy. Int J Endocrinol (2012) 0.75
Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med (2000) 18.26
The Banff 97 working classification of renal allograft pathology. Kidney Int (1999) 9.02
Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant (2008) 8.09
Hepatitis C virus replication in mice with chimeric human livers. Nat Med (2001) 5.87
Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant (2007) 5.39
Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am J Transplant (2011) 4.06
Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant (2009) 3.43
Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant (2010) 3.29
International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int (1993) 3.11
Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology (1996) 2.94
Islet isolation assessment in man and large animals. Acta Diabetol Lat (1991) 2.89
Calcium-dependent chloride currents in isolated cells from rat lacrimal glands. J Physiol (1986) 2.85
The actions of calcium on the mechano-electrical transducer current of turtle hair cells. J Physiol (1991) 2.83
Tolerance versus immunosuppression: a perspective. Am J Transplant (2008) 2.71
Activation and adaptation of transducer currents in turtle hair cells. J Physiol (1989) 2.65
Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes (2001) 2.51
High risk of sensitization after failed islet transplantation. Am J Transplant (2007) 2.29
Banff 2011 Meeting report: new concepts in antibody-mediated rejection. Am J Transplant (2012) 2.28
Microarray analysis of rejection in human kidney transplants using pathogenesis-based transcript sets. Am J Transplant (2007) 2.25
De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant (2009) 2.24
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
Normoglycaemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1991) 2.15
The efficacy of acarbose in the treatment of patients with non-insulin-dependent diabetes mellitus. A multicenter controlled clinical trial. Ann Intern Med (1994) 2.08
FOXP3 expression in human kidney transplant biopsies is associated with rejection and time post transplant but not with favorable outcomes. Am J Transplant (2008) 1.94
A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant (2012) 1.93
Electrical tuning in hair cells isolated from the chick cochlea. J Neurosci (1988) 1.88
Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1. Diabetes (1988) 1.85
Job satisfaction and turnover among nurses: integrating research findings across studies. Nurs Res (1995) 1.82
Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex. J Neurol Sci (1992) 1.79
Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant (2007) 1.78
Interferon expression in the pancreases of patients with type I diabetes. Diabetes (1995) 1.69
Evolution of the MHC class I genes of a New World primate from ancestral homologues of human non-classical genes. Nature (1990) 1.68
Inflammation in areas of tubular atrophy in kidney allograft biopsies: a potent predictor of allograft failure. Am J Transplant (2010) 1.65
NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am J Transplant (2010) 1.62
Th1 to Th2 cytokine shifts in nonobese diabetic mice: sometimes an outcome, rather than the cause, of diabetes resistance elicited by immunostimulation. J Immunol (2001) 1.61
The nature of biopsies with "borderline rejection" and prospects for eliminating this category. Am J Transplant (2011) 1.60
Ischemic acute tubular necrosis induces an extensive local cytokine response. Evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation (1995) 1.59
Potentiation of muscarinic and alpha-adrenergic responses by an analogue of guanosine 5'-triphosphate. Proc Natl Acad Sci U S A (1986) 1.59
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Molecular diagnosis of T cell-mediated rejection in human kidney transplant biopsies. Am J Transplant (2013) 1.57
Glycemic control in insulin-dependent diabetes mellitus. Comparison of outpatient intensified conventional therapy with continuous subcutaneous insulin infusion. Am J Med (1982) 1.56
Potassium currents in hair cells isolated from the cochlea of the chick. J Physiol (1990) 1.54
The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables. Am J Transplant (2010) 1.54
Serine-protease inhibition during islet isolation increases islet yield from human pancreases with prolonged ischemia. Transplantation (2001) 1.54
Glucose-dependent insulin release from genetically engineered K cells. Science (2000) 1.52
Lies, damn lies, and statistics: the perils of the P value. Am J Transplant (2006) 1.50
The molecular landscape of antibody-mediated kidney transplant rejection: evidence for NK involvement through CD16a Fc receptors. Am J Transplant (2015) 1.48
Impaired proinsulin processing is a characteristic of transplanted islets. Am J Transplant (2009) 1.48
Measurement of staff empowerment within health service organizations. J Nurs Meas (1999) 1.47
Large scale isolation, growth, and function of porcine neonatal islet cells. J Clin Invest (1996) 1.46
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45
Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant (2007) 1.44
Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. J Clin Endocrinol Metab (1990) 1.44
The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant (2010) 1.43
No relationship between carbohydrate intake and effect of acarbose on HbA1c or gastrointestinal symptoms in type 2 diabetic subjects consuming 30-60% of energy from carbohydrate. Diabetes Care (1998) 1.42
Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res (1999) 1.41
Awareness and the use of nutritional supplementation for age-related macular degeneration patients. Eye (Lond) (2007) 1.40
Renal failure after eating "magic" mushrooms. CMAJ (1992) 1.40
Blockage of Ca-activated Cl conductance by furosemide in rat lacrimal glands. Pflugers Arch (1986) 1.39
Optimal elective management of patent ductus arteriosus in the older child. J Pediatr Surg (1996) 1.39
Variables in organ donors that affect the recovery of human islets of Langerhans. Transplantation (1996) 1.33
Wound infection prevention by topical antibiotics. Br J Surg (1967) 1.33
Intraductal collagenase delivery into the human pancreas using syringe loading or controlled perfusion. Cell Transplant (1999) 1.31
Revelation of specificity of 64K autoantibodies in IDDM serums by high-resolution 2-D gel electrophoresis. Unambiguous identification of 64K target antigen. Diabetes (1989) 1.30
Clinicopathologic characterization of canine juvenile cellulitis. Vet Pathol (1989) 1.30
Telomere shortening in kidneys with age. J Am Soc Nephrol (2000) 1.29
Cotransplantation of allogeneic islets with allogeneic testicular cell aggregates allows long-term graft survival without systemic immunosuppression. Diabetes (1997) 1.29
Left paraduodenal hernia: an unusual cause of small-bowel obstruction. Can J Surg (2001) 1.29
Delayed graft function in renal transplantation: etiology, management and long-term significance. J Urol (1996) 1.28
The regulation of expression of major histocompatibility complex products. Transplantation (1986) 1.27
Combination therapy with a dipeptidyl peptidase-4 inhibitor and a proton pump inhibitor restores normoglycaemia in non-obese diabetic mice. Diabetologia (2009) 1.27
Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes (1999) 1.25
Calcium currents in hair cells isolated from the cochlea of the chick. J Physiol (1990) 1.25
IFN-gamma alters the pathology of graft rejection: protection from early necrosis. J Immunol (2001) 1.25
Molecular diagnosis of antibody-mediated rejection in human kidney transplants. Am J Transplant (2013) 1.25
Nanophthalmos with uveal effusion: clinical and embryologic considerations. Ophthalmology (1982) 1.23
Immunohistochemical characterisation of cells co-producing insulin and glucagon in the developing human pancreas. Diabetologia (2011) 1.23
Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23
Scoring total inflammation is superior to the current Banff inflammation score in predicting outcome and the degree of molecular disturbance in renal allografts. Am J Transplant (2009) 1.21
HIV prevention heuristics and condom use among African-Americans at risk for HIV. AIDS Care (2005) 1.21
Diagnosing rejection in renal transplants: a comparison of molecular- and histopathology-based approaches. Am J Transplant (2009) 1.19